Table 4.
Final proposed biomarkers for liquid biopsies
| miRNA | Tumor | c_biomarker | e_biomarker | l_biomarker |
|---|---|---|---|---|
| hsa-miR-212-3p | LUAD/lSCC | + | − | + |
| hsa-miR-449a | LUAD | + | − | + |
| hsa-miR-124-3p | lSCC | + | − | + |
| hsa-miR-1304-3p | LUAD/lSCC | + | − | − |
| hsa-miR-137 | LUAD/lSCC | + | − | − |
| hsa-miR-196b-5p | LUAD/lSCC | + | − | + |
| hsa-miR-377-3p | LUAD/lSCC | + | − | − |
| hsa-miR-656-3p | LUAD/lSCC | + | − | − |
| hsa-miR-130b-3p | LUAD/lSCC | + | + | + |
| hsa-miR-182-5p | LUAD/lSCC | + | + | + |
| hsa-miR-203a-3p | LUAD/lSCC | + | + | + |
c_biomarker detectable circulating miRNA in plasma or serum; e_biomarker miRNA detectable in exosomes; l_biomarker detectable miRNA in bronchoalveolar lavage